Global Adalimumab Injection Market Growth 2026-2032
The global Adalimumab Injection market size is predicted to grow from US$ 1031 million in 2025 to US$ 1519 million in 2032; it is expected to grow at a CAGR of 5.8% from 2026 to 2032.
United States market for Adalimumab Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Adalimumab Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Adalimumab Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Adalimumab Injection players cover AbbVie, Amgen, Sandoz, Fresenius Kabi, Biogen, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Adalimumab Injection Industry Forecast? looks at past sales and reviews total world Adalimumab Injection sales in 2025, providing a comprehensive analysis by region and market sector of projected Adalimumab Injection sales for 2026 through 2032. With Adalimumab Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Adalimumab Injection industry.
This Insight Report provides a comprehensive analysis of the global Adalimumab Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Adalimumab Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Adalimumab Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Adalimumab Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Adalimumab Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of Adalimumab Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
United States market for Adalimumab Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Adalimumab Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Adalimumab Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Adalimumab Injection players cover AbbVie, Amgen, Sandoz, Fresenius Kabi, Biogen, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Adalimumab Injection Industry Forecast? looks at past sales and reviews total world Adalimumab Injection sales in 2025, providing a comprehensive analysis by region and market sector of projected Adalimumab Injection sales for 2026 through 2032. With Adalimumab Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Adalimumab Injection industry.
This Insight Report provides a comprehensive analysis of the global Adalimumab Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Adalimumab Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Adalimumab Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Adalimumab Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Adalimumab Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of Adalimumab Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 40mg/0.8ml
- 20mg/0.4ml
- Hospitals
- Clinics
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AbbVie
- Amgen
- Sandoz
- Fresenius Kabi
- Biogen
- Celltrion
- Cadila Pharmaceuticals
- Bio-Thera Solutions, Ltd.
- Hisun Biopharmaceutical
- Innovent Biologics
- Mylan
- Zydus Group
- Boehringer Ingelheim
- Jiangsu Chia Tai-Tianqing Pharmaceutical
- Shanghai Henlius Biotech
- What is the 10-year outlook for the global Adalimumab Injection market?
- What factors are driving Adalimumab Injection market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Adalimumab Injection market opportunities vary by end market size?
- How does Adalimumab Injection break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Adalimumab Injection Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Adalimumab Injection by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Adalimumab Injection by Country/Region, 2021, 2025 & 2032
2.2 Adalimumab Injection Segment by Type
2.2.1 40mg/0.8ml
2.2.2 20mg/0.4ml
2.2.3 Adalimumab Injection Sales by Type
2.2.3.1 Global Adalimumab Injection Sales Market Share by Type (2021-2026)
2.2.3.2 Global Adalimumab Injection Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Adalimumab Injection Sale Price by Type (2021-2026)
2.3 Adalimumab Injection Segment by Application
2.3.1 Hospitals
2.3.2 Clinics
2.3.3 Others
2.3.4 Adalimumab Injection Sales by Application
2.3.4.1 Global Adalimumab Injection Sale Market Share by Application (2021-2026)
2.3.4.2 Global Adalimumab Injection Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Adalimumab Injection Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Adalimumab Injection Breakdown Data by Company
3.1.1 Global Adalimumab Injection Annual Sales by Company (2021-2026)
3.1.2 Global Adalimumab Injection Sales Market Share by Company (2021-2026)
3.2 Global Adalimumab Injection Annual Revenue by Company (2021-2026)
3.2.1 Global Adalimumab Injection Revenue by Company (2021-2026)
3.2.2 Global Adalimumab Injection Revenue Market Share by Company (2021-2026)
3.3 Global Adalimumab Injection Sale Price by Company
3.4 Key Manufacturers Adalimumab Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Adalimumab Injection Product Location Distribution
3.4.2 Players Adalimumab Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ADALIMUMAB INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Adalimumab Injection Market Size by Geographic Region (2021-2026)
4.1.1 Global Adalimumab Injection Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Adalimumab Injection Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Adalimumab Injection Market Size by Country/Region (2021-2026)
4.2.1 Global Adalimumab Injection Annual Sales by Country/Region (2021-2026)
4.2.2 Global Adalimumab Injection Annual Revenue by Country/Region (2021-2026)
4.3 Americas Adalimumab Injection Sales Growth
4.4 APAC Adalimumab Injection Sales Growth
4.5 Europe Adalimumab Injection Sales Growth
4.6 Middle East & Africa Adalimumab Injection Sales Growth
5 AMERICAS
5.1 Americas Adalimumab Injection Sales by Country
5.1.1 Americas Adalimumab Injection Sales by Country (2021-2026)
5.1.2 Americas Adalimumab Injection Revenue by Country (2021-2026)
5.2 Americas Adalimumab Injection Sales by Type (2021-2026)
5.3 Americas Adalimumab Injection Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Adalimumab Injection Sales by Region
6.1.1 APAC Adalimumab Injection Sales by Region (2021-2026)
6.1.2 APAC Adalimumab Injection Revenue by Region (2021-2026)
6.2 APAC Adalimumab Injection Sales by Type (2021-2026)
6.3 APAC Adalimumab Injection Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Adalimumab Injection by Country
7.1.1 Europe Adalimumab Injection Sales by Country (2021-2026)
7.1.2 Europe Adalimumab Injection Revenue by Country (2021-2026)
7.2 Europe Adalimumab Injection Sales by Type (2021-2026)
7.3 Europe Adalimumab Injection Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Adalimumab Injection by Country
8.1.1 Middle East & Africa Adalimumab Injection Sales by Country (2021-2026)
8.1.2 Middle East & Africa Adalimumab Injection Revenue by Country (2021-2026)
8.2 Middle East & Africa Adalimumab Injection Sales by Type (2021-2026)
8.3 Middle East & Africa Adalimumab Injection Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Adalimumab Injection
10.3 Manufacturing Process Analysis of Adalimumab Injection
10.4 Industry Chain Structure of Adalimumab Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Adalimumab Injection Distributors
11.3 Adalimumab Injection Customer
12 WORLD FORECAST REVIEW FOR ADALIMUMAB INJECTION BY GEOGRAPHIC REGION
12.1 Global Adalimumab Injection Market Size Forecast by Region
12.1.1 Global Adalimumab Injection Forecast by Region (2027-2032)
12.1.2 Global Adalimumab Injection Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Adalimumab Injection Forecast by Type (2027-2032)
12.7 Global Adalimumab Injection Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 AbbVie
13.1.1 AbbVie Company Information
13.1.2 AbbVie Adalimumab Injection Product Portfolios and Specifications
13.1.3 AbbVie Adalimumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 AbbVie Main Business Overview
13.1.5 AbbVie Latest Developments
13.2 Amgen
13.2.1 Amgen Company Information
13.2.2 Amgen Adalimumab Injection Product Portfolios and Specifications
13.2.3 Amgen Adalimumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Amgen Main Business Overview
13.2.5 Amgen Latest Developments
13.3 Sandoz
13.3.1 Sandoz Company Information
13.3.2 Sandoz Adalimumab Injection Product Portfolios and Specifications
13.3.3 Sandoz Adalimumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Sandoz Main Business Overview
13.3.5 Sandoz Latest Developments
13.4 Fresenius Kabi
13.4.1 Fresenius Kabi Company Information
13.4.2 Fresenius Kabi Adalimumab Injection Product Portfolios and Specifications
13.4.3 Fresenius Kabi Adalimumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Fresenius Kabi Main Business Overview
13.4.5 Fresenius Kabi Latest Developments
13.5 Biogen
13.5.1 Biogen Company Information
13.5.2 Biogen Adalimumab Injection Product Portfolios and Specifications
13.5.3 Biogen Adalimumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Biogen Main Business Overview
13.5.5 Biogen Latest Developments
13.6 Celltrion
13.6.1 Celltrion Company Information
13.6.2 Celltrion Adalimumab Injection Product Portfolios and Specifications
13.6.3 Celltrion Adalimumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Celltrion Main Business Overview
13.6.5 Celltrion Latest Developments
13.7 Cadila Pharmaceuticals
13.7.1 Cadila Pharmaceuticals Company Information
13.7.2 Cadila Pharmaceuticals Adalimumab Injection Product Portfolios and Specifications
13.7.3 Cadila Pharmaceuticals Adalimumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Cadila Pharmaceuticals Main Business Overview
13.7.5 Cadila Pharmaceuticals Latest Developments
13.8 Bio-Thera Solutions, Ltd.
13.8.1 Bio-Thera Solutions, Ltd. Company Information
13.8.2 Bio-Thera Solutions, Ltd. Adalimumab Injection Product Portfolios and Specifications
13.8.3 Bio-Thera Solutions, Ltd. Adalimumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Bio-Thera Solutions, Ltd. Main Business Overview
13.8.5 Bio-Thera Solutions, Ltd. Latest Developments
13.9 Hisun Biopharmaceutical
13.9.1 Hisun Biopharmaceutical Company Information
13.9.2 Hisun Biopharmaceutical Adalimumab Injection Product Portfolios and Specifications
13.9.3 Hisun Biopharmaceutical Adalimumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Hisun Biopharmaceutical Main Business Overview
13.9.5 Hisun Biopharmaceutical Latest Developments
13.10 Innovent Biologics
13.10.1 Innovent Biologics Company Information
13.10.2 Innovent Biologics Adalimumab Injection Product Portfolios and Specifications
13.10.3 Innovent Biologics Adalimumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Innovent Biologics Main Business Overview
13.10.5 Innovent Biologics Latest Developments
13.11 Mylan
13.11.1 Mylan Company Information
13.11.2 Mylan Adalimumab Injection Product Portfolios and Specifications
13.11.3 Mylan Adalimumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Mylan Main Business Overview
13.11.5 Mylan Latest Developments
13.12 Zydus Group
13.12.1 Zydus Group Company Information
13.12.2 Zydus Group Adalimumab Injection Product Portfolios and Specifications
13.12.3 Zydus Group Adalimumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Zydus Group Main Business Overview
13.12.5 Zydus Group Latest Developments
13.13 Boehringer Ingelheim
13.13.1 Boehringer Ingelheim Company Information
13.13.2 Boehringer Ingelheim Adalimumab Injection Product Portfolios and Specifications
13.13.3 Boehringer Ingelheim Adalimumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Boehringer Ingelheim Main Business Overview
13.13.5 Boehringer Ingelheim Latest Developments
13.14 Jiangsu Chia Tai-Tianqing Pharmaceutical
13.14.1 Jiangsu Chia Tai-Tianqing Pharmaceutical Company Information
13.14.2 Jiangsu Chia Tai-Tianqing Pharmaceutical Adalimumab Injection Product Portfolios and Specifications
13.14.3 Jiangsu Chia Tai-Tianqing Pharmaceutical Adalimumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Jiangsu Chia Tai-Tianqing Pharmaceutical Main Business Overview
13.14.5 Jiangsu Chia Tai-Tianqing Pharmaceutical Latest Developments
13.15 Shanghai Henlius Biotech
13.15.1 Shanghai Henlius Biotech Company Information
13.15.2 Shanghai Henlius Biotech Adalimumab Injection Product Portfolios and Specifications
13.15.3 Shanghai Henlius Biotech Adalimumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Shanghai Henlius Biotech Main Business Overview
13.15.5 Shanghai Henlius Biotech Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Adalimumab Injection Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Adalimumab Injection by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Adalimumab Injection by Country/Region, 2021, 2025 & 2032
2.2 Adalimumab Injection Segment by Type
2.2.1 40mg/0.8ml
2.2.2 20mg/0.4ml
2.2.3 Adalimumab Injection Sales by Type
2.2.3.1 Global Adalimumab Injection Sales Market Share by Type (2021-2026)
2.2.3.2 Global Adalimumab Injection Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Adalimumab Injection Sale Price by Type (2021-2026)
2.3 Adalimumab Injection Segment by Application
2.3.1 Hospitals
2.3.2 Clinics
2.3.3 Others
2.3.4 Adalimumab Injection Sales by Application
2.3.4.1 Global Adalimumab Injection Sale Market Share by Application (2021-2026)
2.3.4.2 Global Adalimumab Injection Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Adalimumab Injection Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Adalimumab Injection Breakdown Data by Company
3.1.1 Global Adalimumab Injection Annual Sales by Company (2021-2026)
3.1.2 Global Adalimumab Injection Sales Market Share by Company (2021-2026)
3.2 Global Adalimumab Injection Annual Revenue by Company (2021-2026)
3.2.1 Global Adalimumab Injection Revenue by Company (2021-2026)
3.2.2 Global Adalimumab Injection Revenue Market Share by Company (2021-2026)
3.3 Global Adalimumab Injection Sale Price by Company
3.4 Key Manufacturers Adalimumab Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Adalimumab Injection Product Location Distribution
3.4.2 Players Adalimumab Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ADALIMUMAB INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Adalimumab Injection Market Size by Geographic Region (2021-2026)
4.1.1 Global Adalimumab Injection Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Adalimumab Injection Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Adalimumab Injection Market Size by Country/Region (2021-2026)
4.2.1 Global Adalimumab Injection Annual Sales by Country/Region (2021-2026)
4.2.2 Global Adalimumab Injection Annual Revenue by Country/Region (2021-2026)
4.3 Americas Adalimumab Injection Sales Growth
4.4 APAC Adalimumab Injection Sales Growth
4.5 Europe Adalimumab Injection Sales Growth
4.6 Middle East & Africa Adalimumab Injection Sales Growth
5 AMERICAS
5.1 Americas Adalimumab Injection Sales by Country
5.1.1 Americas Adalimumab Injection Sales by Country (2021-2026)
5.1.2 Americas Adalimumab Injection Revenue by Country (2021-2026)
5.2 Americas Adalimumab Injection Sales by Type (2021-2026)
5.3 Americas Adalimumab Injection Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Adalimumab Injection Sales by Region
6.1.1 APAC Adalimumab Injection Sales by Region (2021-2026)
6.1.2 APAC Adalimumab Injection Revenue by Region (2021-2026)
6.2 APAC Adalimumab Injection Sales by Type (2021-2026)
6.3 APAC Adalimumab Injection Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Adalimumab Injection by Country
7.1.1 Europe Adalimumab Injection Sales by Country (2021-2026)
7.1.2 Europe Adalimumab Injection Revenue by Country (2021-2026)
7.2 Europe Adalimumab Injection Sales by Type (2021-2026)
7.3 Europe Adalimumab Injection Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Adalimumab Injection by Country
8.1.1 Middle East & Africa Adalimumab Injection Sales by Country (2021-2026)
8.1.2 Middle East & Africa Adalimumab Injection Revenue by Country (2021-2026)
8.2 Middle East & Africa Adalimumab Injection Sales by Type (2021-2026)
8.3 Middle East & Africa Adalimumab Injection Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Adalimumab Injection
10.3 Manufacturing Process Analysis of Adalimumab Injection
10.4 Industry Chain Structure of Adalimumab Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Adalimumab Injection Distributors
11.3 Adalimumab Injection Customer
12 WORLD FORECAST REVIEW FOR ADALIMUMAB INJECTION BY GEOGRAPHIC REGION
12.1 Global Adalimumab Injection Market Size Forecast by Region
12.1.1 Global Adalimumab Injection Forecast by Region (2027-2032)
12.1.2 Global Adalimumab Injection Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Adalimumab Injection Forecast by Type (2027-2032)
12.7 Global Adalimumab Injection Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 AbbVie
13.1.1 AbbVie Company Information
13.1.2 AbbVie Adalimumab Injection Product Portfolios and Specifications
13.1.3 AbbVie Adalimumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 AbbVie Main Business Overview
13.1.5 AbbVie Latest Developments
13.2 Amgen
13.2.1 Amgen Company Information
13.2.2 Amgen Adalimumab Injection Product Portfolios and Specifications
13.2.3 Amgen Adalimumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Amgen Main Business Overview
13.2.5 Amgen Latest Developments
13.3 Sandoz
13.3.1 Sandoz Company Information
13.3.2 Sandoz Adalimumab Injection Product Portfolios and Specifications
13.3.3 Sandoz Adalimumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Sandoz Main Business Overview
13.3.5 Sandoz Latest Developments
13.4 Fresenius Kabi
13.4.1 Fresenius Kabi Company Information
13.4.2 Fresenius Kabi Adalimumab Injection Product Portfolios and Specifications
13.4.3 Fresenius Kabi Adalimumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Fresenius Kabi Main Business Overview
13.4.5 Fresenius Kabi Latest Developments
13.5 Biogen
13.5.1 Biogen Company Information
13.5.2 Biogen Adalimumab Injection Product Portfolios and Specifications
13.5.3 Biogen Adalimumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Biogen Main Business Overview
13.5.5 Biogen Latest Developments
13.6 Celltrion
13.6.1 Celltrion Company Information
13.6.2 Celltrion Adalimumab Injection Product Portfolios and Specifications
13.6.3 Celltrion Adalimumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Celltrion Main Business Overview
13.6.5 Celltrion Latest Developments
13.7 Cadila Pharmaceuticals
13.7.1 Cadila Pharmaceuticals Company Information
13.7.2 Cadila Pharmaceuticals Adalimumab Injection Product Portfolios and Specifications
13.7.3 Cadila Pharmaceuticals Adalimumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Cadila Pharmaceuticals Main Business Overview
13.7.5 Cadila Pharmaceuticals Latest Developments
13.8 Bio-Thera Solutions, Ltd.
13.8.1 Bio-Thera Solutions, Ltd. Company Information
13.8.2 Bio-Thera Solutions, Ltd. Adalimumab Injection Product Portfolios and Specifications
13.8.3 Bio-Thera Solutions, Ltd. Adalimumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Bio-Thera Solutions, Ltd. Main Business Overview
13.8.5 Bio-Thera Solutions, Ltd. Latest Developments
13.9 Hisun Biopharmaceutical
13.9.1 Hisun Biopharmaceutical Company Information
13.9.2 Hisun Biopharmaceutical Adalimumab Injection Product Portfolios and Specifications
13.9.3 Hisun Biopharmaceutical Adalimumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Hisun Biopharmaceutical Main Business Overview
13.9.5 Hisun Biopharmaceutical Latest Developments
13.10 Innovent Biologics
13.10.1 Innovent Biologics Company Information
13.10.2 Innovent Biologics Adalimumab Injection Product Portfolios and Specifications
13.10.3 Innovent Biologics Adalimumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Innovent Biologics Main Business Overview
13.10.5 Innovent Biologics Latest Developments
13.11 Mylan
13.11.1 Mylan Company Information
13.11.2 Mylan Adalimumab Injection Product Portfolios and Specifications
13.11.3 Mylan Adalimumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Mylan Main Business Overview
13.11.5 Mylan Latest Developments
13.12 Zydus Group
13.12.1 Zydus Group Company Information
13.12.2 Zydus Group Adalimumab Injection Product Portfolios and Specifications
13.12.3 Zydus Group Adalimumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Zydus Group Main Business Overview
13.12.5 Zydus Group Latest Developments
13.13 Boehringer Ingelheim
13.13.1 Boehringer Ingelheim Company Information
13.13.2 Boehringer Ingelheim Adalimumab Injection Product Portfolios and Specifications
13.13.3 Boehringer Ingelheim Adalimumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Boehringer Ingelheim Main Business Overview
13.13.5 Boehringer Ingelheim Latest Developments
13.14 Jiangsu Chia Tai-Tianqing Pharmaceutical
13.14.1 Jiangsu Chia Tai-Tianqing Pharmaceutical Company Information
13.14.2 Jiangsu Chia Tai-Tianqing Pharmaceutical Adalimumab Injection Product Portfolios and Specifications
13.14.3 Jiangsu Chia Tai-Tianqing Pharmaceutical Adalimumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Jiangsu Chia Tai-Tianqing Pharmaceutical Main Business Overview
13.14.5 Jiangsu Chia Tai-Tianqing Pharmaceutical Latest Developments
13.15 Shanghai Henlius Biotech
13.15.1 Shanghai Henlius Biotech Company Information
13.15.2 Shanghai Henlius Biotech Adalimumab Injection Product Portfolios and Specifications
13.15.3 Shanghai Henlius Biotech Adalimumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Shanghai Henlius Biotech Main Business Overview
13.15.5 Shanghai Henlius Biotech Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Adalimumab Injection Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Adalimumab Injection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 40mg/0.8ml
Table 4. Major Players of 20mg/0.4ml
Table 5. Global Adalimumab Injection Sales by Type (2021-2026) & (K Units)
Table 6. Global Adalimumab Injection Sales Market Share by Type (2021-2026)
Table 7. Global Adalimumab Injection Revenue by Type (2021-2026) & ($ million)
Table 8. Global Adalimumab Injection Revenue Market Share by Type (2021-2026)
Table 9. Global Adalimumab Injection Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Adalimumab Injection Sale by Application (2021-2026) & (K Units)
Table 11. Global Adalimumab Injection Sale Market Share by Application (2021-2026)
Table 12. Global Adalimumab Injection Revenue by Application (2021-2026) & ($ million)
Table 13. Global Adalimumab Injection Revenue Market Share by Application (2021-2026)
Table 14. Global Adalimumab Injection Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Adalimumab Injection Sales by Company (2021-2026) & (K Units)
Table 16. Global Adalimumab Injection Sales Market Share by Company (2021-2026)
Table 17. Global Adalimumab Injection Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Adalimumab Injection Revenue Market Share by Company (2021-2026)
Table 19. Global Adalimumab Injection Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Adalimumab Injection Producing Area Distribution and Sales Area
Table 21. Players Adalimumab Injection Products Offered
Table 22. Adalimumab Injection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Adalimumab Injection Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Adalimumab Injection Sales Market Share Geographic Region (2021-2026)
Table 27. Global Adalimumab Injection Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Adalimumab Injection Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Adalimumab Injection Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Adalimumab Injection Sales Market Share by Country/Region (2021-2026)
Table 31. Global Adalimumab Injection Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Adalimumab Injection Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Adalimumab Injection Sales by Country (2021-2026) & (K Units)
Table 34. Americas Adalimumab Injection Sales Market Share by Country (2021-2026)
Table 35. Americas Adalimumab Injection Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Adalimumab Injection Sales by Type (2021-2026) & (K Units)
Table 37. Americas Adalimumab Injection Sales by Application (2021-2026) & (K Units)
Table 38. APAC Adalimumab Injection Sales by Region (2021-2026) & (K Units)
Table 39. APAC Adalimumab Injection Sales Market Share by Region (2021-2026)
Table 40. APAC Adalimumab Injection Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Adalimumab Injection Sales by Type (2021-2026) & (K Units)
Table 42. APAC Adalimumab Injection Sales by Application (2021-2026) & (K Units)
Table 43. Europe Adalimumab Injection Sales by Country (2021-2026) & (K Units)
Table 44. Europe Adalimumab Injection Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Adalimumab Injection Sales by Type (2021-2026) & (K Units)
Table 46. Europe Adalimumab Injection Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Adalimumab Injection Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Adalimumab Injection Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Adalimumab Injection Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Adalimumab Injection Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Adalimumab Injection
Table 52. Key Market Challenges & Risks of Adalimumab Injection
Table 53. Key Industry Trends of Adalimumab Injection
Table 54. Adalimumab Injection Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Adalimumab Injection Distributors List
Table 57. Adalimumab Injection Customer List
Table 58. Global Adalimumab Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Adalimumab Injection Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Adalimumab Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Adalimumab Injection Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Adalimumab Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Adalimumab Injection Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Adalimumab Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Adalimumab Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Adalimumab Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Adalimumab Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Adalimumab Injection Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Adalimumab Injection Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Adalimumab Injection Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Adalimumab Injection Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. AbbVie Basic Information, Adalimumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 73. AbbVie Adalimumab Injection Product Portfolios and Specifications
Table 74. AbbVie Adalimumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. AbbVie Main Business
Table 76. AbbVie Latest Developments
Table 77. Amgen Basic Information, Adalimumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 78. Amgen Adalimumab Injection Product Portfolios and Specifications
Table 79. Amgen Adalimumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Amgen Main Business
Table 81. Amgen Latest Developments
Table 82. Sandoz Basic Information, Adalimumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 83. Sandoz Adalimumab Injection Product Portfolios and Specifications
Table 84. Sandoz Adalimumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Sandoz Main Business
Table 86. Sandoz Latest Developments
Table 87. Fresenius Kabi Basic Information, Adalimumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 88. Fresenius Kabi Adalimumab Injection Product Portfolios and Specifications
Table 89. Fresenius Kabi Adalimumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Fresenius Kabi Main Business
Table 91. Fresenius Kabi Latest Developments
Table 92. Biogen Basic Information, Adalimumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 93. Biogen Adalimumab Injection Product Portfolios and Specifications
Table 94. Biogen Adalimumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Biogen Main Business
Table 96. Biogen Latest Developments
Table 97. Celltrion Basic Information, Adalimumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 98. Celltrion Adalimumab Injection Product Portfolios and Specifications
Table 99. Celltrion Adalimumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Celltrion Main Business
Table 101. Celltrion Latest Developments
Table 102. Cadila Pharmaceuticals Basic Information, Adalimumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 103. Cadila Pharmaceuticals Adalimumab Injection Product Portfolios and Specifications
Table 104. Cadila Pharmaceuticals Adalimumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Cadila Pharmaceuticals Main Business
Table 106. Cadila Pharmaceuticals Latest Developments
Table 107. Bio-Thera Solutions, Ltd. Basic Information, Adalimumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 108. Bio-Thera Solutions, Ltd. Adalimumab Injection Product Portfolios and Specifications
Table 109. Bio-Thera Solutions, Ltd. Adalimumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Bio-Thera Solutions, Ltd. Main Business
Table 111. Bio-Thera Solutions, Ltd. Latest Developments
Table 112. Hisun Biopharmaceutical Basic Information, Adalimumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 113. Hisun Biopharmaceutical Adalimumab Injection Product Portfolios and Specifications
Table 114. Hisun Biopharmaceutical Adalimumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Hisun Biopharmaceutical Main Business
Table 116. Hisun Biopharmaceutical Latest Developments
Table 117. Innovent Biologics Basic Information, Adalimumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 118. Innovent Biologics Adalimumab Injection Product Portfolios and Specifications
Table 119. Innovent Biologics Adalimumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Innovent Biologics Main Business
Table 121. Innovent Biologics Latest Developments
Table 122. Mylan Basic Information, Adalimumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 123. Mylan Adalimumab Injection Product Portfolios and Specifications
Table 124. Mylan Adalimumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Mylan Main Business
Table 126. Mylan Latest Developments
Table 127. Zydus Group Basic Information, Adalimumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 128. Zydus Group Adalimumab Injection Product Portfolios and Specifications
Table 129. Zydus Group Adalimumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Zydus Group Main Business
Table 131. Zydus Group Latest Developments
Table 132. Boehringer Ingelheim Basic Information, Adalimumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 133. Boehringer Ingelheim Adalimumab Injection Product Portfolios and Specifications
Table 134. Boehringer Ingelheim Adalimumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Boehringer Ingelheim Main Business
Table 136. Boehringer Ingelheim Latest Developments
Table 137. Jiangsu Chia Tai-Tianqing Pharmaceutical Basic Information, Adalimumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 138. Jiangsu Chia Tai-Tianqing Pharmaceutical Adalimumab Injection Product Portfolios and Specifications
Table 139. Jiangsu Chia Tai-Tianqing Pharmaceutical Adalimumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. Jiangsu Chia Tai-Tianqing Pharmaceutical Main Business
Table 141. Jiangsu Chia Tai-Tianqing Pharmaceutical Latest Developments
Table 142. Shanghai Henlius Biotech Basic Information, Adalimumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 143. Shanghai Henlius Biotech Adalimumab Injection Product Portfolios and Specifications
Table 144. Shanghai Henlius Biotech Adalimumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 145. Shanghai Henlius Biotech Main Business
Table 146. Shanghai Henlius Biotech Latest Developments
Table 1. Adalimumab Injection Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Adalimumab Injection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 40mg/0.8ml
Table 4. Major Players of 20mg/0.4ml
Table 5. Global Adalimumab Injection Sales by Type (2021-2026) & (K Units)
Table 6. Global Adalimumab Injection Sales Market Share by Type (2021-2026)
Table 7. Global Adalimumab Injection Revenue by Type (2021-2026) & ($ million)
Table 8. Global Adalimumab Injection Revenue Market Share by Type (2021-2026)
Table 9. Global Adalimumab Injection Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Adalimumab Injection Sale by Application (2021-2026) & (K Units)
Table 11. Global Adalimumab Injection Sale Market Share by Application (2021-2026)
Table 12. Global Adalimumab Injection Revenue by Application (2021-2026) & ($ million)
Table 13. Global Adalimumab Injection Revenue Market Share by Application (2021-2026)
Table 14. Global Adalimumab Injection Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Adalimumab Injection Sales by Company (2021-2026) & (K Units)
Table 16. Global Adalimumab Injection Sales Market Share by Company (2021-2026)
Table 17. Global Adalimumab Injection Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Adalimumab Injection Revenue Market Share by Company (2021-2026)
Table 19. Global Adalimumab Injection Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Adalimumab Injection Producing Area Distribution and Sales Area
Table 21. Players Adalimumab Injection Products Offered
Table 22. Adalimumab Injection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Adalimumab Injection Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Adalimumab Injection Sales Market Share Geographic Region (2021-2026)
Table 27. Global Adalimumab Injection Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Adalimumab Injection Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Adalimumab Injection Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Adalimumab Injection Sales Market Share by Country/Region (2021-2026)
Table 31. Global Adalimumab Injection Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Adalimumab Injection Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Adalimumab Injection Sales by Country (2021-2026) & (K Units)
Table 34. Americas Adalimumab Injection Sales Market Share by Country (2021-2026)
Table 35. Americas Adalimumab Injection Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Adalimumab Injection Sales by Type (2021-2026) & (K Units)
Table 37. Americas Adalimumab Injection Sales by Application (2021-2026) & (K Units)
Table 38. APAC Adalimumab Injection Sales by Region (2021-2026) & (K Units)
Table 39. APAC Adalimumab Injection Sales Market Share by Region (2021-2026)
Table 40. APAC Adalimumab Injection Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Adalimumab Injection Sales by Type (2021-2026) & (K Units)
Table 42. APAC Adalimumab Injection Sales by Application (2021-2026) & (K Units)
Table 43. Europe Adalimumab Injection Sales by Country (2021-2026) & (K Units)
Table 44. Europe Adalimumab Injection Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Adalimumab Injection Sales by Type (2021-2026) & (K Units)
Table 46. Europe Adalimumab Injection Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Adalimumab Injection Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Adalimumab Injection Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Adalimumab Injection Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Adalimumab Injection Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Adalimumab Injection
Table 52. Key Market Challenges & Risks of Adalimumab Injection
Table 53. Key Industry Trends of Adalimumab Injection
Table 54. Adalimumab Injection Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Adalimumab Injection Distributors List
Table 57. Adalimumab Injection Customer List
Table 58. Global Adalimumab Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Adalimumab Injection Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Adalimumab Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Adalimumab Injection Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Adalimumab Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Adalimumab Injection Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Adalimumab Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Adalimumab Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Adalimumab Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Adalimumab Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Adalimumab Injection Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Adalimumab Injection Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Adalimumab Injection Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Adalimumab Injection Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. AbbVie Basic Information, Adalimumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 73. AbbVie Adalimumab Injection Product Portfolios and Specifications
Table 74. AbbVie Adalimumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. AbbVie Main Business
Table 76. AbbVie Latest Developments
Table 77. Amgen Basic Information, Adalimumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 78. Amgen Adalimumab Injection Product Portfolios and Specifications
Table 79. Amgen Adalimumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Amgen Main Business
Table 81. Amgen Latest Developments
Table 82. Sandoz Basic Information, Adalimumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 83. Sandoz Adalimumab Injection Product Portfolios and Specifications
Table 84. Sandoz Adalimumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Sandoz Main Business
Table 86. Sandoz Latest Developments
Table 87. Fresenius Kabi Basic Information, Adalimumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 88. Fresenius Kabi Adalimumab Injection Product Portfolios and Specifications
Table 89. Fresenius Kabi Adalimumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Fresenius Kabi Main Business
Table 91. Fresenius Kabi Latest Developments
Table 92. Biogen Basic Information, Adalimumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 93. Biogen Adalimumab Injection Product Portfolios and Specifications
Table 94. Biogen Adalimumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Biogen Main Business
Table 96. Biogen Latest Developments
Table 97. Celltrion Basic Information, Adalimumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 98. Celltrion Adalimumab Injection Product Portfolios and Specifications
Table 99. Celltrion Adalimumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Celltrion Main Business
Table 101. Celltrion Latest Developments
Table 102. Cadila Pharmaceuticals Basic Information, Adalimumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 103. Cadila Pharmaceuticals Adalimumab Injection Product Portfolios and Specifications
Table 104. Cadila Pharmaceuticals Adalimumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Cadila Pharmaceuticals Main Business
Table 106. Cadila Pharmaceuticals Latest Developments
Table 107. Bio-Thera Solutions, Ltd. Basic Information, Adalimumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 108. Bio-Thera Solutions, Ltd. Adalimumab Injection Product Portfolios and Specifications
Table 109. Bio-Thera Solutions, Ltd. Adalimumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Bio-Thera Solutions, Ltd. Main Business
Table 111. Bio-Thera Solutions, Ltd. Latest Developments
Table 112. Hisun Biopharmaceutical Basic Information, Adalimumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 113. Hisun Biopharmaceutical Adalimumab Injection Product Portfolios and Specifications
Table 114. Hisun Biopharmaceutical Adalimumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Hisun Biopharmaceutical Main Business
Table 116. Hisun Biopharmaceutical Latest Developments
Table 117. Innovent Biologics Basic Information, Adalimumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 118. Innovent Biologics Adalimumab Injection Product Portfolios and Specifications
Table 119. Innovent Biologics Adalimumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Innovent Biologics Main Business
Table 121. Innovent Biologics Latest Developments
Table 122. Mylan Basic Information, Adalimumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 123. Mylan Adalimumab Injection Product Portfolios and Specifications
Table 124. Mylan Adalimumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Mylan Main Business
Table 126. Mylan Latest Developments
Table 127. Zydus Group Basic Information, Adalimumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 128. Zydus Group Adalimumab Injection Product Portfolios and Specifications
Table 129. Zydus Group Adalimumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Zydus Group Main Business
Table 131. Zydus Group Latest Developments
Table 132. Boehringer Ingelheim Basic Information, Adalimumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 133. Boehringer Ingelheim Adalimumab Injection Product Portfolios and Specifications
Table 134. Boehringer Ingelheim Adalimumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Boehringer Ingelheim Main Business
Table 136. Boehringer Ingelheim Latest Developments
Table 137. Jiangsu Chia Tai-Tianqing Pharmaceutical Basic Information, Adalimumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 138. Jiangsu Chia Tai-Tianqing Pharmaceutical Adalimumab Injection Product Portfolios and Specifications
Table 139. Jiangsu Chia Tai-Tianqing Pharmaceutical Adalimumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. Jiangsu Chia Tai-Tianqing Pharmaceutical Main Business
Table 141. Jiangsu Chia Tai-Tianqing Pharmaceutical Latest Developments
Table 142. Shanghai Henlius Biotech Basic Information, Adalimumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 143. Shanghai Henlius Biotech Adalimumab Injection Product Portfolios and Specifications
Table 144. Shanghai Henlius Biotech Adalimumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 145. Shanghai Henlius Biotech Main Business
Table 146. Shanghai Henlius Biotech Latest Developments
LIST OF FIGURES
Figure 1. Picture of Adalimumab Injection
Figure 2. Adalimumab Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Adalimumab Injection Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Adalimumab Injection Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Adalimumab Injection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Adalimumab Injection Sales Market Share by Country/Region (2025)
Figure 10. Adalimumab Injection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 40mg/0.8ml
Figure 12. Product Picture of 20mg/0.4ml
Figure 13. Global Adalimumab Injection Sales Market Share by Type in 2026
Figure 14. Global Adalimumab Injection Revenue Market Share by Type (2021-2026)
Figure 15. Adalimumab Injection Consumed in Hospitals
Figure 16. Global Adalimumab Injection Market: Hospitals (2021-2026) & (K Units)
Figure 17. Adalimumab Injection Consumed in Clinics
Figure 18. Global Adalimumab Injection Market: Clinics (2021-2026) & (K Units)
Figure 19. Adalimumab Injection Consumed in Others
Figure 20. Global Adalimumab Injection Market: Others (2021-2026) & (K Units)
Figure 21. Global Adalimumab Injection Sale Market Share by Application (2025)
Figure 22. Global Adalimumab Injection Revenue Market Share by Application in 2026
Figure 23. Adalimumab Injection Sales by Company in 2026 (K Units)
Figure 24. Global Adalimumab Injection Sales Market Share by Company in 2026
Figure 25. Adalimumab Injection Revenue by Company in 2026 ($ millions)
Figure 26. Global Adalimumab Injection Revenue Market Share by Company in 2026
Figure 27. Global Adalimumab Injection Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Adalimumab Injection Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Adalimumab Injection Sales 2021-2026 (K Units)
Figure 30. Americas Adalimumab Injection Revenue 2021-2026 ($ millions)
Figure 31. APAC Adalimumab Injection Sales 2021-2026 (K Units)
Figure 32. APAC Adalimumab Injection Revenue 2021-2026 ($ millions)
Figure 33. Europe Adalimumab Injection Sales 2021-2026 (K Units)
Figure 34. Europe Adalimumab Injection Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Adalimumab Injection Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Adalimumab Injection Revenue 2021-2026 ($ millions)
Figure 37. Americas Adalimumab Injection Sales Market Share by Country in 2026
Figure 38. Americas Adalimumab Injection Revenue Market Share by Country (2021-2026)
Figure 39. Americas Adalimumab Injection Sales Market Share by Type (2021-2026)
Figure 40. Americas Adalimumab Injection Sales Market Share by Application (2021-2026)
Figure 41. United States Adalimumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Adalimumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Adalimumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Adalimumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Adalimumab Injection Sales Market Share by Region in 2026
Figure 46. APAC Adalimumab Injection Revenue Market Share by Region (2021-2026)
Figure 47. APAC Adalimumab Injection Sales Market Share by Type (2021-2026)
Figure 48. APAC Adalimumab Injection Sales Market Share by Application (2021-2026)
Figure 49. China Adalimumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Adalimumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Adalimumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Adalimumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 53. India Adalimumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Adalimumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Adalimumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Adalimumab Injection Sales Market Share by Country in 2026
Figure 57. Europe Adalimumab Injection Revenue Market Share by Country (2021-2026)
Figure 58. Europe Adalimumab Injection Sales Market Share by Type (2021-2026)
Figure 59. Europe Adalimumab Injection Sales Market Share by Application (2021-2026)
Figure 60. Germany Adalimumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 61. France Adalimumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Adalimumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Adalimumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Adalimumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Adalimumab Injection Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Adalimumab Injection Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Adalimumab Injection Sales Market Share by Application (2021-2026)
Figure 68. Egypt Adalimumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Adalimumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Adalimumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Adalimumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Adalimumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Adalimumab Injection in 2026
Figure 74. Manufacturing Process Analysis of Adalimumab Injection
Figure 75. Industry Chain Structure of Adalimumab Injection
Figure 76. Channels of Distribution
Figure 77. Global Adalimumab Injection Sales Market Forecast by Region (2027-2032)
Figure 78. Global Adalimumab Injection Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Adalimumab Injection Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Adalimumab Injection Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Adalimumab Injection Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Adalimumab Injection Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Adalimumab Injection
Figure 2. Adalimumab Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Adalimumab Injection Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Adalimumab Injection Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Adalimumab Injection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Adalimumab Injection Sales Market Share by Country/Region (2025)
Figure 10. Adalimumab Injection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 40mg/0.8ml
Figure 12. Product Picture of 20mg/0.4ml
Figure 13. Global Adalimumab Injection Sales Market Share by Type in 2026
Figure 14. Global Adalimumab Injection Revenue Market Share by Type (2021-2026)
Figure 15. Adalimumab Injection Consumed in Hospitals
Figure 16. Global Adalimumab Injection Market: Hospitals (2021-2026) & (K Units)
Figure 17. Adalimumab Injection Consumed in Clinics
Figure 18. Global Adalimumab Injection Market: Clinics (2021-2026) & (K Units)
Figure 19. Adalimumab Injection Consumed in Others
Figure 20. Global Adalimumab Injection Market: Others (2021-2026) & (K Units)
Figure 21. Global Adalimumab Injection Sale Market Share by Application (2025)
Figure 22. Global Adalimumab Injection Revenue Market Share by Application in 2026
Figure 23. Adalimumab Injection Sales by Company in 2026 (K Units)
Figure 24. Global Adalimumab Injection Sales Market Share by Company in 2026
Figure 25. Adalimumab Injection Revenue by Company in 2026 ($ millions)
Figure 26. Global Adalimumab Injection Revenue Market Share by Company in 2026
Figure 27. Global Adalimumab Injection Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Adalimumab Injection Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Adalimumab Injection Sales 2021-2026 (K Units)
Figure 30. Americas Adalimumab Injection Revenue 2021-2026 ($ millions)
Figure 31. APAC Adalimumab Injection Sales 2021-2026 (K Units)
Figure 32. APAC Adalimumab Injection Revenue 2021-2026 ($ millions)
Figure 33. Europe Adalimumab Injection Sales 2021-2026 (K Units)
Figure 34. Europe Adalimumab Injection Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Adalimumab Injection Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Adalimumab Injection Revenue 2021-2026 ($ millions)
Figure 37. Americas Adalimumab Injection Sales Market Share by Country in 2026
Figure 38. Americas Adalimumab Injection Revenue Market Share by Country (2021-2026)
Figure 39. Americas Adalimumab Injection Sales Market Share by Type (2021-2026)
Figure 40. Americas Adalimumab Injection Sales Market Share by Application (2021-2026)
Figure 41. United States Adalimumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Adalimumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Adalimumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Adalimumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Adalimumab Injection Sales Market Share by Region in 2026
Figure 46. APAC Adalimumab Injection Revenue Market Share by Region (2021-2026)
Figure 47. APAC Adalimumab Injection Sales Market Share by Type (2021-2026)
Figure 48. APAC Adalimumab Injection Sales Market Share by Application (2021-2026)
Figure 49. China Adalimumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Adalimumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Adalimumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Adalimumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 53. India Adalimumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Adalimumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Adalimumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Adalimumab Injection Sales Market Share by Country in 2026
Figure 57. Europe Adalimumab Injection Revenue Market Share by Country (2021-2026)
Figure 58. Europe Adalimumab Injection Sales Market Share by Type (2021-2026)
Figure 59. Europe Adalimumab Injection Sales Market Share by Application (2021-2026)
Figure 60. Germany Adalimumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 61. France Adalimumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Adalimumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Adalimumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Adalimumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Adalimumab Injection Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Adalimumab Injection Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Adalimumab Injection Sales Market Share by Application (2021-2026)
Figure 68. Egypt Adalimumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Adalimumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Adalimumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Adalimumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Adalimumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Adalimumab Injection in 2026
Figure 74. Manufacturing Process Analysis of Adalimumab Injection
Figure 75. Industry Chain Structure of Adalimumab Injection
Figure 76. Channels of Distribution
Figure 77. Global Adalimumab Injection Sales Market Forecast by Region (2027-2032)
Figure 78. Global Adalimumab Injection Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Adalimumab Injection Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Adalimumab Injection Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Adalimumab Injection Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Adalimumab Injection Revenue Market Share Forecast by Application (2027-2032)
